Skip to main content

Table 1 Baseline characteristics of the study population

From: Neutrophils to high-density lipoprotein cholesterol ratio as a new prognostic marker in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: a retrospective study

Variable

MACE-free (n = 460)

MACE (n = 72)

P

Age (y)

63 (53–72)

66 (60–75)

0.014

Male/female (n)

372/88

52/20

0.124

SBP on admission (mmHg)

125 (108–145)

117 (98–136)

0.003

DBP on admission (mmHg)

75 (66–88)

70 (61–82)

0.007

Smoking (n, %)

323 (70.2)

46 (63.9)

0.279

Hypertension (n, %)

245 (53.3)

31 (43.1)

0.107

Diabetes (n, %)

148 (32.2)

22 (30.6)

0.784

MYO (ng/ml)

500 (209–500)

500 (177–500)

0.493

CK-MB (µg/L)

27.6 (4.8–65.5)

13.9 (4.2–61.2)

0.406

cTn I (ng/ml)

3.61 (0.28–16.20)

1.32 (0.22–17.1)

0.923

WBC (×109/L)

10.69 (8.70–12.89)

11.90 (9.42–16.85)

0.002

RBC (×1012/L)

4.54 (4.15–4.90)

4.47 (4.15–4.92)

0.603

Hemoglobin (g/l)

138 (126–150)

139 (127–152)

0.978

platelet count (×109/L)

189 (153–234)

189 (142–236)

0.624

Neutrophil count (×109/L)

8.97 (7.00–11.02)

9.97 (7.86–13.82)

0.001

Lymphocyte count (×109/L)

1.13 (0.79–1.57)

1.16 (0.81–1.70)

0.472

Monocyte count (×109/L)

0.42 (0.30–0.55)

0.48 (0.34–0.70)

0.043

ALT (U/L)

40 (28–55)

58 (41–93)

< 0.001

AST (U/L)

99 (45–215)

178 (61–366)

0.004

Urea nitrogen (mmol/L)

5.7 (4.8–6.8)

5.8 (4.8–7.4)

0.357

Creatinine (µmol/L)

72 (62–85)

81 (66–100)

0.001

UA (µmol/L)

346 (285–397)

362 (295–431)

0.096

TC (mmol/L)

4.44 (3.81–5.18)

4.26 (3.52–4.98)

0.247

TG (mmol/L)

1.55 (1.00–2.27)

1.49 (0.94–2.12)

0.426

LDL-c (mmol/L)

2.92 (2.29–3.54)

2.74 (2.12–3.56)

0.224

HDL-c (mmol/L)

1.09 (0.93–1.30)

1.03 (0.88–1.29)

0.492

hs-CRP (mg/L)

4.95 (2.04–10.19)

6.67 (2.87–19.57)

0.005

FPG (mmol/L)

6.7 (5.8–8.3)

8.0 (6.9–9.9)

< 0.001

HbA1c (%)

6.0 (5.7–6.8)

6.2 (5.8–6.8)

0.128

Gensini score

72 (39–89)

80 (44–97)

0.070

Killip III-IV (%)

31 (6.7)

39 (55.7)

< 0.001

LVEF (%)

57 (52–60)

55 (45–60)

0.012

NHR

8.13 (5.89–11.16)

10.93 (6.26–13.97)

0.001

  1. ALT, Alanine transaminase; AST, aspartate aminopherase; CK-MB, creatine kinase isoenzyme; cTn I, cardiac troponin I; DBP, diastolic blood pressure; FPG, fasting plasma glucose; HDL-c, high-density lipoprotein cholesterol; hs-CRP, high-sensitivity C-reactive protein; HbA1c, hemoglobin A1c; LDL-c, low-density lipoprotein cholesterol; LVEF: left ventricular ejection fraction; MACE, major adverse cardiac events; MYO, myoglobin; NHR neutrophils count to high-density lipoprotein cholesterol ratio; RBC, red blood count; SBP, systolic blood pressure; TC, total cholesterol; TG, triglyceride; UA, uric acid; WBC, white blood count
Back to article page

BMC Cardiovascular Disorders

ISSN: 1471-2261

Contact us